Published in Clin Cancer Res on January 01, 2001
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell (2002) 5.06
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. Blood (2005) 1.24
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance. BMC Cancer (2010) 1.16
Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3. Neoplasia (2010) 1.14
Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Neoplasia (2002) 1.11
A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med (2012) 1.03
Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells. Br J Pharmacol (2004) 1.02
Effects of lovastatin on breast cancer cells: a proteo-metabonomic study. Breast Cancer Res (2010) 1.00
Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity. Cell Death Dis (2011) 0.98
Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells. Br J Pharmacol (2009) 0.89
Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity. Dig Liver Dis (2011) 0.87
Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide. Br J Pharmacol (2006) 0.87
Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells. PLoS One (2012) 0.87
Autocrine amplification loop in statin-induced apoptosis of human melanoma cells. Br J Pharmacol (2009) 0.87
Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. PLoS One (2010) 0.84
Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol (2003) 0.84
Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci (2014) 0.83
Lovastatin lowers the risk of breast cancer: a population-based study using logistic regression with a random effects model. Springerplus (2016) 0.82
Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy. PLoS One (2012) 0.82
Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation. Oncotarget (2015) 0.81
Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis. J Cancer (2016) 0.80
Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck. Transl Oncol (2014) 0.80
Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway. Oncotarget (2016) 0.80
Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice. Endocrinology (2014) 0.79
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Pharmacol Exp Ther (2007) 0.79
Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade. Sci Rep (2016) 0.77
Statin-dependent activation of protein kinase Cδ in acute promyelocytic leukemia cells and induction of leukemic cell differentiation. Leuk Lymphoma (2012) 0.77
Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells. Br J Pharmacol (2014) 0.77
Statins inhibit the proliferation and induce cell death of human papilloma virus positive and negative cervical cancer cells. Int J Biomed Sci (2009) 0.77
Simvastatin-induced compartmentalisation of doxorubicin sharpens up nuclear topoisomerase II inhibition in human rhabdomyosarcoma cells. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.77
The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy. Front Oncol (2015) 0.76
A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies. J Transl Med (2016) 0.75
Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer. Open Access J Urol (2011) 0.75
In vitro Anti-Tumor Effects of Statins on Head and Neck Squamous Cell Carcinoma: A Systematic Review. PLoS One (2015) 0.75
Telomerase Inhibitory Effects of Red Pigment Rubropunctatin and Statin Monacolin L Isolated from Red Yeast Rice. Genes (Basel) (2017) 0.75
Marketed drugs used for the management of hypercholesterolemia as anticancer armament. Onco Targets Ther (2017) 0.75
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell (1990) 8.30
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol (2000) 8.08
The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J (2000) 7.54
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol (1996) 7.02
The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J (2001) 5.69
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07
Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon-exon junctions. Genes Dev (2000) 3.74
Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J (1996) 3.68
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med (1997) 3.57
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet (1996) 3.08
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med (1990) 3.01
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia (2002) 2.89
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J (1998) 2.86
Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N Engl J Med (1998) 2.85
Branch nucleophile selection in pre-mRNA splicing: evidence for the bulged duplex model. Genes Dev (1994) 2.63
Oxygen sensing in airway chemoreceptors. Nature (1993) 2.35
Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet (1996) 2.32
P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med (1991) 2.32
Eye contact and face scanning in early infancy. Science (1977) 2.20
Structure of the detoxification catalyst mercuric ion reductase from Bacillus sp. strain RC607. Nature (1991) 2.01
Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98
A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia, and application to routine histopathology. Acta Neuropathol (1986) 1.98
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol (1999) 1.93
novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol (1998) 1.90
Myc represses the growth arrest gene gadd45. Oncogene (1997) 1.86
The C2 domain of the ubiquitin protein ligase Nedd4 mediates Ca2+-dependent plasma membrane localization. J Biol Chem (1997) 1.85
Induction of increased calcium uptake in mouse T lymphocytes by concanavalin A and its modulation by cyclic nucleotides. Nature (1975) 1.82
The human Prp8 protein is a component of both U2- and U12-dependent spliceosomes. RNA (1999) 1.81
Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita. Bone Marrow Transplant (2003) 1.80
Expression of the chloride channel ClC-2 in the murine small intestine epithelium. Am J Physiol Cell Physiol (2000) 1.75
Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol (1997) 1.74
Precursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol Cell (2001) 1.72
Bimolecular exon ligation by the human spliceosome. Science (1997) 1.72
The C-terminal region of hPrp8 interacts with the conserved GU dinucleotide at the 5' splice site. RNA (1999) 1.71
Use of a site-directed triple mutant to trap intermediates: demonstration that the flavin C(4a)-thiol adduct and reduced flavin are kinetically competent intermediates in mercuric ion reductase. Biochemistry (1990) 1.63
Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol Cell Biol (2001) 1.61
A model of human acute lymphoblastic leukemia in immune-deficient SCID mice. Science (1989) 1.60
OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol (1998) 1.59
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J Cell Sci (2001) 1.59
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res (1995) 1.57
Deadly diving? Physiological and behavioural management of decompression stress in diving mammals. Proc Biol Sci (2011) 1.57
Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer (1999) 1.55
Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med (1973) 1.53
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell (1990) 1.52
Intravenous diazepam in the treatment of prolonged seizure activity. N Engl J Med (1967) 1.50
Expression of gastrin-releasing peptide receptor gene in developing lung. Am J Respir Cell Mol Biol (1996) 1.49
A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). Blood (1991) 1.47
A direct quantitative measure of surface mobility in a glassy polymer. Science (2014) 1.47
The obstacles to maximising the impact of public access defibrillation: an assessment of the dispatch mechanism for out-of-hospital cardiac arrest. Heart (2007) 1.46
Targeting tumor cell metabolism with statins. Oncogene (2012) 1.46
Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol (1990) 1.45
Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood (1999) 1.45
Diagnosis and treatment of adrenal tumours: a review of 35 years' experience. Br J Urol (1998) 1.45
Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia. Blood (1994) 1.45
Alternative donor bone marrow transplantation for children with juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol (2000) 1.42
Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart (2007) 1.42
NADPH-oxidase and a hydrogen peroxide-sensitive K+ channel may function as an oxygen sensor complex in airway chemoreceptors and small cell lung carcinoma cell lines. Proc Natl Acad Sci U S A (1996) 1.41
Thrombocytopenia with absent radii: frequency of marrow megakaryocyte progenitors, proliferative characteristics, and megakaryocyte growth and development factor responsiveness. Pediatr Hematol Oncol (2000) 1.40
Serial studies of auditory neurotoxicity in patients receiving deferoxamine therapy. Am J Med (1987) 1.39
Intron recognition comes of AGe. Nat Struct Biol (2000) 1.38
Determination of the tautomeric form of the imidazole ring of L-histidine in basic solution by carbon-13 magnetic resonance spectroscopy. J Am Chem Soc (1973) 1.37
Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood (1984) 1.36
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. J Clin Oncol (2003) 1.35
Fusion of retinoic acid receptor alpha to NuMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia. Nat Genet (1997) 1.34
The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol Cell Biol (1997) 1.33
Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of cytochrome c is a late event. Oncogene (2001) 1.32
Type-C retrovirus maturation and assembly: post-translational cleavage of the gag-gene coded precursor polypeptide occurs at the cell membrane. Virology (1978) 1.32
Biometric analyses of normal skeletal muscle. Acta Neuropathol (1971) 1.31
Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med (1985) 1.30
Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol (2000) 1.30
Soluble antigen-antibody complexes as intermediates in the purification of antibodies in 8 molar urea. Arch Biochem Biophys (1966) 1.30
Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science (1990) 1.29
Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science (1990) 1.28
Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia (2001) 1.27
Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology (1999) 1.26
Carbon-13 nuclear magnetic resonance titration shifts in amino acids. J Am Chem Soc (1974) 1.26
Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25
Drinking and schooling. J Health Econ (1993) 1.24
Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. Am J Pathol (1996) 1.24
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer. Br J Cancer (2006) 1.24
Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach. Blood (1999) 1.24
Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Hum Mutat (1998) 1.23
Expression of the human NOV gene in first trimester fetal tissues. Anat Embryol (Berl) (2001) 1.23
Strychnine blocks binaural inhibition in lateral superior olivary neurons. J Neurosci (1983) 1.23
Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods. Cancer (1983) 1.23
Immune function in patients with Shwachman-Diamond syndrome. Br J Haematol (2001) 1.21
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group. J Clin Oncol (2005) 1.21
Immunolocalization of the ubiquitin-protein ligase Nedd4 in tissues expressing the epithelial Na+ channel (ENaC). Am J Physiol (1997) 1.21
Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Cancer Res (2000) 1.20
Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood (1992) 1.19
The effects of complete modification of amino groups on the antibody activity of antihapten antibodies. Reversible inactivation with maleic anhydride. Biochemistry (1968) 1.19
Molecular basis of bacterial resistance to organomercurial and inorganic mercuric salts. FASEB J (1988) 1.19
Evidence for a linear search in bimolecular 3' splice site AG selection. Proc Natl Acad Sci U S A (2000) 1.17